0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs for Treating Mental Disorders Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-26Q10074
Home | Market Reports | Health | Mental Health
Global Drugs for Treating Mental Disorders Market Insights and Forecast to 2028

Global Drugs for Treating Mental Disorders Market Insights and Forecast to 2028

Code: QYRE-Auto-26Q10074
Report
May 2022
126 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Drugs for Treating Mental Disorders Market

The global Drugs for Treating Mental Disorders market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Tablets accounting for % of the Drugs for Treating Mental Disorders global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Antipsychotics segment is altered to an % CAGR throughout this forecast period.
China Drugs for Treating Mental Disorders market size is valued at US$ million in 2021, while the North America and Europe Drugs for Treating Mental Disorders are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Drugs for Treating Mental Disorders landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drugs for Treating Mental Disorders market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drugs for Treating Mental Disorders market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drugs for Treating Mental Disorders market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drugs for Treating Mental Disorders market.
Global Drugs for Treating Mental Disorders Scope and Market Size
Drugs for Treating Mental Disorders market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Drugs for Treating Mental Disorders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Tablets
Capsule
Injection
Solution
Other

Segment by Application

Antipsychotics
Antidepressants
Antianxiety (Anxiolyitcs)
Anti-Seizure Medications
Stimulants
Cognitive Disorders And Dementia
Sleep Disorder Treatments
Substance Abuse Treatments
Hypnosis And Tranquilizers

BY COMPANY

Johnson and Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Teva Pharmaceutical
Dr. Reddy's Laboratories
Apotex Inc.
Mylan Pharmaceuticals
Par Pharmaceutical
Aurobindo Pharma
Torrent Pharmaceuticals
Jubilant Lifesciences
Sun Pharmaceutical
Sandoz (Novartis)
Hansoh Pharmaceutical
WATSON Pharmaceuticals
Zhejiang Langhua Pharmaceuticals
Forest Laboratories
H.Lundbeck A/S
Amneal Pharmaceuticals
Hetero Drugs
Macleods Pharmaceuticals
Silarx Pharmacueticals
Hikma Pharmaceuticals
Lupin Limited
Prinston Pharmaceutical
STI Pharma

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Treating Mental Disorders Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Injection
1.2.5 Solution
1.2.6 Other
1.3 Market by Application
1.3.1 Global Drugs for Treating Mental Disorders Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Antipsychotics
1.3.3 Antidepressants
1.3.4 Antianxiety (Anxiolyitcs)
1.3.5 Anti-Seizure Medications
1.3.6 Stimulants
1.3.7 Cognitive Disorders And Dementia
1.3.8 Sleep Disorder Treatments
1.3.9 Substance Abuse Treatments
1.3.10 Hypnosis And Tranquilizers
1.3.11 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Treating Mental Disorders Market Perspective (2017-2028)
2.2 Drugs for Treating Mental Disorders Growth Trends by Region
2.2.1 Drugs for Treating Mental Disorders Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drugs for Treating Mental Disorders Historic Market Size by Region (2017-2022)
2.2.3 Drugs for Treating Mental Disorders Forecasted Market Size by Region (2023-2028)
2.3 Drugs for Treating Mental Disorders Market Dynamics
2.3.1 Drugs for Treating Mental Disorders Industry Trends
2.3.2 Drugs for Treating Mental Disorders Market Drivers
2.3.3 Drugs for Treating Mental Disorders Market Challenges
2.3.4 Drugs for Treating Mental Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Treating Mental Disorders Players by Revenue
3.1.1 Global Top Drugs for Treating Mental Disorders Players by Revenue (2017-2022)
3.1.2 Global Drugs for Treating Mental Disorders Revenue Market Share by Players (2017-2022)
3.2 Global Drugs for Treating Mental Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Treating Mental Disorders Revenue
3.4 Global Drugs for Treating Mental Disorders Market Concentration Ratio
3.4.1 Global Drugs for Treating Mental Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Treating Mental Disorders Revenue in 2021
3.5 Drugs for Treating Mental Disorders Key Players Head office and Area Served
3.6 Key Players Drugs for Treating Mental Disorders Product Solution and Service
3.7 Date of Enter into Drugs for Treating Mental Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Treating Mental Disorders Breakdown Data by Type
4.1 Global Drugs for Treating Mental Disorders Historic Market Size by Type (2017-2022)
4.2 Global Drugs for Treating Mental Disorders Forecasted Market Size by Type (2023-2028)
5 Drugs for Treating Mental Disorders Breakdown Data by Application
5.1 Global Drugs for Treating Mental Disorders Historic Market Size by Application (2017-2022)
5.2 Global Drugs for Treating Mental Disorders Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drugs for Treating Mental Disorders Market Size (2017-2028)
6.2 North America Drugs for Treating Mental Disorders Market Size by Type
6.2.1 North America Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
6.2.2 North America Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
6.2.3 North America Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
6.3 North America Drugs for Treating Mental Disorders Market Size by Application
6.3.1 North America Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
6.3.2 North America Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
6.3.3 North America Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
6.4 North America Drugs for Treating Mental Disorders Market Size by Country
6.4.1 North America Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
6.4.2 North America Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Drugs for Treating Mental Disorders Market Size (2017-2028)
7.2 Europe Drugs for Treating Mental Disorders Market Size by Type
7.2.1 Europe Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
7.2.2 Europe Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
7.2.3 Europe Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
7.3 Europe Drugs for Treating Mental Disorders Market Size by Application
7.3.1 Europe Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
7.3.2 Europe Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
7.3.3 Europe Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
7.4 Europe Drugs for Treating Mental Disorders Market Size by Country
7.4.1 Europe Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
7.4.2 Europe Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size (2017-2028)
8.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Type
8.2.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
8.3 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Application
8.3.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
8.4 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region
8.4.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drugs for Treating Mental Disorders Market Size (2017-2028)
9.2 Latin America Drugs for Treating Mental Disorders Market Size by Type
9.2.1 Latin America Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
9.2.2 Latin America Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
9.2.3 Latin America Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
9.3 Latin America Drugs for Treating Mental Disorders Market Size by Application
9.3.1 Latin America Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
9.3.2 Latin America Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
9.3.3 Latin America Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
9.4 Latin America Drugs for Treating Mental Disorders Market Size by Country
9.4.1 Latin America Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
9.4.2 Latin America Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size (2017-2028)
10.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type
10.2.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
10.3 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application
10.3.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
10.4 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country
10.4.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Introduction
11.1.4 Johnson and Johnson Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.1.5 Johnson and Johnson Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drugs for Treating Mental Disorders Introduction
11.2.4 Pfizer Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Drugs for Treating Mental Disorders Introduction
11.3.4 Eli Lilly Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.3.5 Eli Lilly Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Introduction
11.4.4 GlaxoSmithKline Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Drugs for Treating Mental Disorders Introduction
11.5.4 AstraZeneca Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.5.5 AstraZeneca Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Introduction
11.6.4 Bristol-Myers Squibb Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.7.4 Teva Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.7.5 Teva Pharmaceutical Recent Developments
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Details
11.8.2 Dr. Reddy's Laboratories Business Overview
11.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.8.5 Dr. Reddy's Laboratories Recent Developments
11.9 Apotex Inc.
11.9.1 Apotex Inc. Company Details
11.9.2 Apotex Inc. Business Overview
11.9.3 Apotex Inc. Drugs for Treating Mental Disorders Introduction
11.9.4 Apotex Inc. Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.9.5 Apotex Inc. Recent Developments
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Details
11.10.2 Mylan Pharmaceuticals Business Overview
11.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.10.4 Mylan Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.10.5 Mylan Pharmaceuticals Recent Developments
11.11 Par Pharmaceutical
11.11.1 Par Pharmaceutical Company Details
11.11.2 Par Pharmaceutical Business Overview
11.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.11.4 Par Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.11.5 Par Pharmaceutical Recent Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Details
11.12.2 Aurobindo Pharma Business Overview
11.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Introduction
11.12.4 Aurobindo Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.12.5 Aurobindo Pharma Recent Developments
11.13 Torrent Pharmaceuticals
11.13.1 Torrent Pharmaceuticals Company Details
11.13.2 Torrent Pharmaceuticals Business Overview
11.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.13.4 Torrent Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.13.5 Torrent Pharmaceuticals Recent Developments
11.14 Jubilant Lifesciences
11.14.1 Jubilant Lifesciences Company Details
11.14.2 Jubilant Lifesciences Business Overview
11.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Introduction
11.14.4 Jubilant Lifesciences Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.14.5 Jubilant Lifesciences Recent Developments
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Details
11.15.2 Sun Pharmaceutical Business Overview
11.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.15.4 Sun Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.15.5 Sun Pharmaceutical Recent Developments
11.16 Sandoz (Novartis)
11.16.1 Sandoz (Novartis) Company Details
11.16.2 Sandoz (Novartis) Business Overview
11.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Introduction
11.16.4 Sandoz (Novartis) Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.16.5 Sandoz (Novartis) Recent Developments
11.17 Hansoh Pharmaceutical
11.17.1 Hansoh Pharmaceutical Company Details
11.17.2 Hansoh Pharmaceutical Business Overview
11.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.17.4 Hansoh Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.17.5 Hansoh Pharmaceutical Recent Developments
11.18 WATSON Pharmaceuticals
11.18.1 WATSON Pharmaceuticals Company Details
11.18.2 WATSON Pharmaceuticals Business Overview
11.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.18.4 WATSON Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.18.5 WATSON Pharmaceuticals Recent Developments
11.19 Zhejiang Langhua Pharmaceuticals
11.19.1 Zhejiang Langhua Pharmaceuticals Company Details
11.19.2 Zhejiang Langhua Pharmaceuticals Business Overview
11.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.19.4 Zhejiang Langhua Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.19.5 Zhejiang Langhua Pharmaceuticals Recent Developments
11.20 Forest Laboratories
11.20.1 Forest Laboratories Company Details
11.20.2 Forest Laboratories Business Overview
11.20.3 Forest Laboratories Drugs for Treating Mental Disorders Introduction
11.20.4 Forest Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.20.5 Forest Laboratories Recent Developments
11.21 H.Lundbeck A/S
11.21.1 H.Lundbeck A/S Company Details
11.21.2 H.Lundbeck A/S Business Overview
11.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Introduction
11.21.4 H.Lundbeck A/S Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.21.5 H.Lundbeck A/S Recent Developments
11.22 Amneal Pharmaceuticals
11.22.1 Amneal Pharmaceuticals Company Details
11.22.2 Amneal Pharmaceuticals Business Overview
11.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.22.4 Amneal Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.22.5 Amneal Pharmaceuticals Recent Developments
11.23 Hetero Drugs
11.23.1 Hetero Drugs Company Details
11.23.2 Hetero Drugs Business Overview
11.23.3 Hetero Drugs Drugs for Treating Mental Disorders Introduction
11.23.4 Hetero Drugs Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.23.5 Hetero Drugs Recent Developments
11.24 Macleods Pharmaceuticals
11.24.1 Macleods Pharmaceuticals Company Details
11.24.2 Macleods Pharmaceuticals Business Overview
11.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.24.4 Macleods Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.24.5 Macleods Pharmaceuticals Recent Developments
11.25 Silarx Pharmacueticals
11.25.1 Silarx Pharmacueticals Company Details
11.25.2 Silarx Pharmacueticals Business Overview
11.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Introduction
11.25.4 Silarx Pharmacueticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.25.5 Silarx Pharmacueticals Recent Developments
11.26 Hikma Pharmaceuticals
11.26.1 Hikma Pharmaceuticals Company Details
11.26.2 Hikma Pharmaceuticals Business Overview
11.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.26.4 Hikma Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.26.5 Hikma Pharmaceuticals Recent Developments
11.27 Lupin Limited
11.27.1 Lupin Limited Company Details
11.27.2 Lupin Limited Business Overview
11.27.3 Lupin Limited Drugs for Treating Mental Disorders Introduction
11.27.4 Lupin Limited Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.27.5 Lupin Limited Recent Developments
11.28 Prinston Pharmaceutical
11.28.1 Prinston Pharmaceutical Company Details
11.28.2 Prinston Pharmaceutical Business Overview
11.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.28.4 Prinston Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.28.5 Prinston Pharmaceutical Recent Developments
11.29 STI Pharma
11.29.1 STI Pharma Company Details
11.29.2 STI Pharma Business Overview
11.29.3 STI Pharma Drugs for Treating Mental Disorders Introduction
11.29.4 STI Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.29.5 STI Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Drugs for Treating Mental Disorders Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Tablets
    Table 3. Key Players of Capsule
    Table 4. Key Players of Injection
    Table 5. Key Players of Solution
    Table 6. Key Players of Other
    Table 7. Global Drugs for Treating Mental Disorders Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Drugs for Treating Mental Disorders Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Drugs for Treating Mental Disorders Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Drugs for Treating Mental Disorders Market Share by Region (2017-2022)
    Table 11. Global Drugs for Treating Mental Disorders Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Drugs for Treating Mental Disorders Market Share by Region (2023-2028)
    Table 13. Drugs for Treating Mental Disorders Market Trends
    Table 14. Drugs for Treating Mental Disorders Market Drivers
    Table 15. Drugs for Treating Mental Disorders Market Challenges
    Table 16. Drugs for Treating Mental Disorders Market Restraints
    Table 17. Global Drugs for Treating Mental Disorders Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Drugs for Treating Mental Disorders Revenue Share by Players (2017-2022)
    Table 19. Global Top Drugs for Treating Mental Disorders by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Treating Mental Disorders as of 2021)
    Table 20. Ranking of Global Top Drugs for Treating Mental Disorders Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Drugs for Treating Mental Disorders Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Drugs for Treating Mental Disorders Product Solution and Service
    Table 24. Date of Enter into Drugs for Treating Mental Disorders Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Drugs for Treating Mental Disorders Revenue Market Share by Type (2017-2022)
    Table 28. Global Drugs for Treating Mental Disorders Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Drugs for Treating Mental Disorders Revenue Market Share by Type (2023-2028)
    Table 30. Global Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Drugs for Treating Mental Disorders Revenue Share by Application (2017-2022)
    Table 32. Global Drugs for Treating Mental Disorders Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Drugs for Treating Mental Disorders Revenue Share by Application (2023-2028)
    Table 34. North America Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Drugs for Treating Mental Disorders Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Drugs for Treating Mental Disorders Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Johnson and Johnson Company Details
    Table 65. Johnson and Johnson Business Overview
    Table 66. Johnson and Johnson Drugs for Treating Mental Disorders Product
    Table 67. Johnson and Johnson Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 68. Johnson and Johnson Recent Developments
    Table 69. Pfizer Company Details
    Table 70. Pfizer Business Overview
    Table 71. Pfizer Drugs for Treating Mental Disorders Product
    Table 72. Pfizer Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 73. Pfizer Recent Developments
    Table 74. Eli Lilly Company Details
    Table 75. Eli Lilly Business Overview
    Table 76. Eli Lilly Drugs for Treating Mental Disorders Product
    Table 77. Eli Lilly Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 78. Eli Lilly Recent Developments
    Table 79. GlaxoSmithKline Company Details
    Table 80. GlaxoSmithKline Business Overview
    Table 81. GlaxoSmithKline Drugs for Treating Mental Disorders Product
    Table 82. GlaxoSmithKline Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 83. GlaxoSmithKline Recent Developments
    Table 84. AstraZeneca Company Details
    Table 85. AstraZeneca Business Overview
    Table 86. AstraZeneca Drugs for Treating Mental Disorders Product
    Table 87. AstraZeneca Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 88. AstraZeneca Recent Developments
    Table 89. Bristol-Myers Squibb Company Details
    Table 90. Bristol-Myers Squibb Business Overview
    Table 91. Bristol-Myers Squibb Drugs for Treating Mental Disorders Product
    Table 92. Bristol-Myers Squibb Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 93. Bristol-Myers Squibb Recent Developments
    Table 94. Teva Pharmaceutical Company Details
    Table 95. Teva Pharmaceutical Business Overview
    Table 96. Teva Pharmaceutical Drugs for Treating Mental Disorders Product
    Table 97. Teva Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 98. Teva Pharmaceutical Recent Developments
    Table 99. Dr. Reddy's Laboratories Company Details
    Table 100. Dr. Reddy's Laboratories Business Overview
    Table 101. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product
    Table 102. Dr. Reddy's Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 103. Dr. Reddy's Laboratories Recent Developments
    Table 104. Apotex Inc. Company Details
    Table 105. Apotex Inc. Business Overview
    Table 106. Apotex Inc. Drugs for Treating Mental Disorders Product
    Table 107. Apotex Inc. Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 108. Apotex Inc. Recent Developments
    Table 109. Mylan Pharmaceuticals Company Details
    Table 110. Mylan Pharmaceuticals Business Overview
    Table 111. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product
    Table 112. Mylan Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 113. Mylan Pharmaceuticals Recent Developments
    Table 114. Par Pharmaceutical Company Details
    Table 115. Par Pharmaceutical Business Overview
    Table 116. Par Pharmaceutical Drugs for Treating Mental Disorders Product
    Table 117. Par Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 118. Par Pharmaceutical Recent Developments
    Table 119. Aurobindo Pharma Company Details
    Table 120. Aurobindo Pharma Business Overview
    Table 121. Aurobindo Pharma Drugs for Treating Mental Disorders Product
    Table 122. Aurobindo Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 123. Aurobindo Pharma Recent Developments
    Table 124. Torrent Pharmaceuticals Company Details
    Table 125. Torrent Pharmaceuticals Business Overview
    Table 126. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product
    Table 127. Torrent Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 128. Torrent Pharmaceuticals Recent Developments
    Table 129. Jubilant Lifesciences Company Details
    Table 130. Jubilant Lifesciences Business Overview
    Table 131. Jubilant Lifesciences Drugs for Treating Mental Disorders Product
    Table 132. Jubilant Lifesciences Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 133. Jubilant Lifesciences Recent Developments
    Table 134. Sun Pharmaceutical Company Details
    Table 135. Sun Pharmaceutical Business Overview
    Table 136. Sun Pharmaceutical Drugs for Treating Mental Disorders Product
    Table 137. Sun Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 138. Sun Pharmaceutical Recent Developments
    Table 139. Sandoz (Novartis) Company Details
    Table 140. Sandoz (Novartis) Business Overview
    Table 141. Sandoz (Novartis) Drugs for Treating Mental Disorders Product
    Table 142. Sandoz (Novartis) Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 143. Sandoz (Novartis) Recent Developments
    Table 144. Hansoh Pharmaceutical Company Details
    Table 145. Hansoh Pharmaceutical Business Overview
    Table 146. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Product
    Table 147. Hansoh Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 148. Hansoh Pharmaceutical Recent Developments
    Table 149. WATSON Pharmaceuticals Company Details
    Table 150. WATSON Pharmaceuticals Business Overview
    Table 151. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Product
    Table 152. WATSON Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 153. WATSON Pharmaceuticals Recent Developments
    Table 154. Zhejiang Langhua Pharmaceuticals Company Details
    Table 155. Zhejiang Langhua Pharmaceuticals Business Overview
    Table 156. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Product
    Table 157. Zhejiang Langhua Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 158. Zhejiang Langhua Pharmaceuticals Recent Developments
    Table 159. Forest Laboratories Company Details
    Table 160. Forest Laboratories Business Overview
    Table 161. Forest Laboratories Drugs for Treating Mental Disorders Product
    Table 162. Forest Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 163. Forest Laboratories Recent Developments
    Table 164. H.Lundbeck A/S Company Details
    Table 165. H.Lundbeck A/S Business Overview
    Table 166. H.Lundbeck A/S Drugs for Treating Mental Disorders Product
    Table 167. H.Lundbeck A/S Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 168. H.Lundbeck A/S Recent Developments
    Table 169. Amneal Pharmaceuticals Company Details
    Table 170. Amneal Pharmaceuticals Business Overview
    Table 171. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Product
    Table 172. Amneal Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 173. Amneal Pharmaceuticals Recent Developments
    Table 174. Hetero Drugs Company Details
    Table 175. Hetero Drugs Business Overview
    Table 176. Hetero Drugs Drugs for Treating Mental Disorders Product
    Table 177. Hetero Drugs Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 178. Hetero Drugs Recent Developments
    Table 179. Macleods Pharmaceuticals Company Details
    Table 180. Macleods Pharmaceuticals Business Overview
    Table 181. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Product
    Table 182. Macleods Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 183. Macleods Pharmaceuticals Recent Developments
    Table 184. Silarx Pharmacueticals Company Details
    Table 185. Silarx Pharmacueticals Business Overview
    Table 186. Silarx Pharmacueticals Drugs for Treating Mental Disorders Product
    Table 187. Silarx Pharmacueticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 188. Silarx Pharmacueticals Recent Developments
    Table 189. Hikma Pharmaceuticals Company Details
    Table 190. Hikma Pharmaceuticals Business Overview
    Table 191. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Product
    Table 192. Hikma Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 193. Hikma Pharmaceuticals Recent Developments
    Table 194. Lupin Limited Company Details
    Table 195. Lupin Limited Business Overview
    Table 196. Lupin Limited Drugs for Treating Mental Disorders Product
    Table 197. Lupin Limited Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 198. Lupin Limited Recent Developments
    Table 199. Prinston Pharmaceutical Company Details
    Table 200. Prinston Pharmaceutical Business Overview
    Table 201. Prinston Pharmaceutical Drugs for Treating Mental Disorders Product
    Table 202. Prinston Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 203. Prinston Pharmaceutical Recent Developments
    Table 204. STI Pharma Company Details
    Table 205. STI Pharma Business Overview
    Table 206. STI Pharma Drugs for Treating Mental Disorders Product
    Table 207. STI Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
    Table 208. STI Pharma Recent Developments
    Table 209. Research Programs/Design for This Report
    Table 210. Key Data Information from Secondary Sources
    Table 211. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drugs for Treating Mental Disorders Market Share by Type: 2021 VS 2028
    Figure 2. Tablets Features
    Figure 3. Capsule Features
    Figure 4. Injection Features
    Figure 5. Solution Features
    Figure 6. Other Features
    Figure 7. Global Drugs for Treating Mental Disorders Market Share by Application: 2021 VS 2028
    Figure 8. Antipsychotics Case Studies
    Figure 9. Antidepressants Case Studies
    Figure 10. Antianxiety (Anxiolyitcs) Case Studies
    Figure 11. Anti-Seizure Medications Case Studies
    Figure 12. Stimulants Case Studies
    Figure 13. Cognitive Disorders And Dementia Case Studies
    Figure 14. Sleep Disorder Treatments Case Studies
    Figure 15. Substance Abuse Treatments Case Studies
    Figure 16. Hypnosis And Tranquilizers Case Studies
    Figure 17. Other Case Studies
    Figure 18. Drugs for Treating Mental Disorders Report Years Considered
    Figure 19. Global Drugs for Treating Mental Disorders Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 20. Global Drugs for Treating Mental Disorders Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 21. Global Drugs for Treating Mental Disorders Market Share by Region: 2021 VS 2028
    Figure 22. Global Drugs for Treating Mental Disorders Market Share by Players in 2021
    Figure 23. Global Top Drugs for Treating Mental Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Treating Mental Disorders as of 2021)
    Figure 24. The Top 10 and 5 Players Market Share by Drugs for Treating Mental Disorders Revenue in 2021
    Figure 25. North America Drugs for Treating Mental Disorders Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. North America Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2028)
    Figure 27. North America Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2028)
    Figure 28. North America Drugs for Treating Mental Disorders Market Size Share by Country (2017-2028)
    Figure 29. United States Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Canada Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Europe Drugs for Treating Mental Disorders Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Europe Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2028)
    Figure 33. Europe Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2028)
    Figure 34. Europe Drugs for Treating Mental Disorders Market Size Share by Country (2017-2028)
    Figure 35. Germany Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. France Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. U.K. Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Italy Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Russia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Nordic Countries Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Asia-Pacific Drugs for Treating Mental Disorders Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Asia Pacific Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2028)
    Figure 43. Asia Pacific Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2028)
    Figure 44. Asia Pacific Drugs for Treating Mental Disorders Market Size Share by Region (2017-2028)
    Figure 45. China Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Japan Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. South Korea Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Southeast Asia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. India Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Australia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 51. Latin America Drugs for Treating Mental Disorders Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Latin America Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2028)
    Figure 53. Latin America Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2028)
    Figure 54. Latin America Drugs for Treating Mental Disorders Market Size Share by Country (2017-2028)
    Figure 55. Mexico Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Brazil Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Middle East & Africa Drugs for Treating Mental Disorders Market Size YoY (2017-2028) & (US$ Million)
    Figure 58. Middle East and Africa Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2028)
    Figure 59. Middle East and Africa Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2028)
    Figure 60. Middle East and Africa Drugs for Treating Mental Disorders Market Size Share by Country (2017-2028)
    Figure 61. Turkey Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 62. Saudi Arabia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 63. UAE Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 64. Johnson and Johnson Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 65. Pfizer Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 66. Eli Lilly Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 67. GlaxoSmithKline Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 68. AstraZeneca Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 70. Teva Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 71. Dr. Reddy's Laboratories Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 72. Apotex Inc. Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 73. Mylan Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 74. Par Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 75. Aurobindo Pharma Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 76. Torrent Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 77. Jubilant Lifesciences Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 78. Sun Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 79. Sandoz (Novartis) Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 80. Hansoh Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 81. WATSON Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 82. Zhejiang Langhua Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 83. Forest Laboratories Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 84. H.Lundbeck A/S Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 85. Amneal Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 86. Hetero Drugs Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 87. Macleods Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 88. Silarx Pharmacueticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 89. Hikma Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 90. Lupin Limited Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 91. Prinston Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 92. STI Pharma Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD